SI-BONE (NASDAQ:SIBN – Free Report) had its price objective reduced by Needham & Company LLC from $32.00 to $25.00 in a research note released on Tuesday, Benzinga reports. They currently have a buy rating on the stock. SIBN has been the subject of several other research reports. Truist Financial cut their price objective on SI-BONE […]
SI-BONE, Inc. (NASDAQ:SIBN – Get Free Report) CFO Anshul Maheshwari sold 1,244 shares of the firm’s stock in a transaction on Monday, October 2nd. The stock was sold at an average price of $21.15, for a total transaction of $26,310.60. Following the transaction, the chief financial officer now directly owns 150,471 shares of the company’s […]
SI-BONE, Inc. (NASDAQ:SIBN – Get Free Report) insider Anthony J. Recupero sold 1,712 shares of the firm’s stock in a transaction on Monday, October 2nd. The stock was sold at an average price of $21.16, for a total transaction of $36,225.92. Following the transaction, the insider now directly owns 209,296 shares of the company’s stock, […]
SI-BONE, Inc. (NASDAQ:SIBN – Get Free Report) has been given an average rating of “Buy” by the seven brokerages that are covering the stock, MarketBeat.com reports. Seven research analysts have rated the stock with a buy rating. The average 1 year target price among brokers that have issued ratings on the stock in the last […]
SI-BONE, Inc. (NASDAQ:SIBN – Get Free Report) saw a significant drop in short interest in August. As of August 31st, there was short interest totalling 742,500 shares, a drop of 22.3% from the August 15th total of 955,900 shares. Based on an average daily trading volume, of 375,000 shares, the days-to-cover ratio is presently 2.0 […]